Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-07-18 00:00:00 ET · period of report 2023-07-14 · accession 0001209191-23-042566 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-18 | 2023-07-17 | VRTX | SACHS BRUCE I | Dir | S - Sale+OE | $356.75 | -11.2K | 49.6K | -19% | -$4.01M |
| D | 2023-07-18 | 2023-07-17 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $127.54 | +11.2K | 51.2K | +28% | +$1.43M |
| D | 2023-07-18 | 2023-07-17 | VRTX | SACHS BRUCE I | Dir | M - OptEx | $0.00 | -11.2K | 11.2K | -50% | $0 |
| D | 2023-07-18 | 2023-07-14 | VRTX | SACHS BRUCE I | Dir | A - Grant | $350.79 | +124.72 | 14.5K | +0.9% | +$43.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-17 | S | D | 5,711 | $356.75 | 43,842 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $356.75 (range $356.00 to $356.99). (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-07-17 | S | D | 3,842 | $357.29 | 40,000 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $357.29 (range $357.00 to $357.38). (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-07-17 | S | D | 1,697 | $355.54 | 49,553 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $355.54 (range $355.00 to $355.97). (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2023-07-17 | M | A | 11,250 | $127.54 | 51,250 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-07-17 | M | D | 11,250 | $0.00 | 11,250 | D | $127.54 · — to 2025-05-31 | 11,250 Common Stock | (F7) Fully vested. |
| 6 | Derivative | Deferred Stock Units | 2023-07-14 | A | A | 124.72 | $350.79 | 14,524.97 | D | — · — to — | 124.72 Common Stock | (F6) Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death. |